![logo](/logos/NYXH.webp)
Nyxoah S.A.
NASDAQ:NYXH
7.51 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Nyxoah S.A. |
Symbool | NYXH |
Munteenheid | USD |
Prijs | 7.51 |
Beurswaarde | 258,046,604 |
Dividendpercentage | 0% |
52-weken bereik | 4 - 20 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Olivier Taelman |
Website | https://www.nyxoah.com |
An error occurred while fetching data.
Over Nyxoah S.A.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)